Clinical Trials in Atlanta

Showing 5021-5040 of 19,805 trials

Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

NCT05685004

This randomized study is designed to compare the combination of TVI-Brain-1 immunotherapy and standard therapy compared to standard therapy alone as a treatment for newly diagnosed MGMT unmethylated glioblastoma patients. The patients' own cancer cells collected after surgery are combined into a vaccine to produce an immune response that significantly increases the number of cancer neoantigen-specific effector T cell precursors in the patient's body. These cancer neoantigen-specific T cells are harvested from the blood, subsequently stimulated and expanded, and infused back into the patient.

Glioblastoma Multiforme of Brain

TVAX Biomedical120 participantsStarted Sep 2023

Tucson, Arizona, United States • Los Angeles, California, United States • Los Angeles, California, United States +5 more locations

COMPLETEDPhase 25.6 miles

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

NCT05568706

This is a Phase 2b, randomized, double-blind, placebo-controlled study of EDP-938 administered orally for the treatment of non-hospitalized adult subjects with confirmed RSV infection who are at high risk for complications after RSV infection.

RSV Infection

Enanta Pharmaceuticals, Inc186 participantsStarted Nov 2022

Tempe, Arizona, United States • Fresno, California, United States • Lomita, California, United States +81 more locations

Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

Find Trials by Condition in Atlanta

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

A Study to Investigate LYL797 in Adults With Solid Tumors

A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Depression Trial)

Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Vaginal Ecosystem and Network in the United States Study

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

Distal Radius Interventions for Fracture Treatment

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

A Study to Investigate LYL845 in Adults With Solid Tumors

Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)

Beacon Sensors and Telerehabilitation for Low Vision

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates